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ABSTRACT
PURPOSE: Wilson disease (WD) is an autosomal recessively inherited disorder of copper accumulation and 
toxicity. Its recognition is easy in the presence of typical clinical presentations. Unexplained liver test ab-
normalities are a diagnostic challenge and require more examinations. The objective of this study is to as-
sess the diagnostic value of ceruloplasmin, 24-hour urine copper excretion and Leipzig scoring system in 
WD.
MATERIAL AND METHODS: Sixty-five patients with WD (22 females and 43 males) and a control group of 
17 patients with other chronic liver diseases (CLD) were analyzed. The values of the parameters of copper 
metabolism and Leipzig scoring system were evaluated.
RESULTS: Average ceruloplasmin level was under 0,2 g/L and 24-hour urinary copper concentration was in-
creased. D-penicillamine challenge test showed a mean value of 17,4 µmol/24 hours of urinary copper ex-
cretion in WD patients versus 5,46 µmol/24 hours in CLD ones. According to the Leipzig scoring diagnostic 
criteria, 58 WD patients (89,23% of the cases) presented with a score ≥4 (maximal value of 12). Score 3 was 
found out in seven patients, however, the exclusion of other etiology and the clinical course of the disease 
confirmed the diagnosis. The control subjects presented with a score ≤3 as it was ≤2 in 76,5% of the cases.
CONCLUSION: Our results confirm the diagnostic value for WD of the Leipzig scoring system combined 
with clinical symptoms, laboratory parameters of copper metabolism, genetic testing and liver biopsy in 
clinical practice.
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INTRODUCTION
Wilson’s disease (WD) is a rare autosomal he-
reditary recessive disorder of copper metabolism. It 
is characterized by progressive copper accumulation 
and toxic action in the organism, mainly in the liver, 
brain, cornea, and kidneys. The disease can be treat-
ed in the case of timely recognition (3,6). The diagno-
sis is easy in the presence of typical manifestations. A 
vague liver disease or isolated symptoms originating 
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from other organs and systems present a diagnostic 
challenge and require additional examinations (8,16).
The objective of this study is to reveal the di-
agnostic value of serum ceruloplasmin, 24-hour uri-
nary copper excretion and Leipzig scoring system in 
WD.
MATERIAL AND METHODS
The study covered 65 WD patients, 22 females 
and 43 males at a mean age of 37,75±12,98 years 
(range, 18-65 years) hospitalised and followed-up in 
the Clinic of Gastroenterology, St. Marina Universi-
ty Hospital of Varna, during the period from 2003 
till 2013 as well as 17 patients with other chronic liver 
diseases (CLD) serving as controls. The levels of se-
rum ceruloplasmin as well as of basal and provoked 
24-hour urinary copper expression were examined. 
Leipzig scoring system for WD diagnosis was used 
for the evaluation of the patients from both groups. 
This system includes both clinical and labora-
tory parameters with score range between one and 
four. The diagnosis of WD is established in case of 
≥4 scores. In case of 3 scores, the diagnosis is possi-
ble and additional examinations are needed while in 
case of ≤2 scores, the diagnosis is less probable.
The following statistical methods were made 
use of: descriptive statistics, analysis of univariate 
and multivariate empirical distributions, indepen-
dent samples test, and t-test for equality of means. 
A p-value of 0,05 was defined as statistically signifi-
cant. Statistical data processing was done by using of 
SPSS 13.0 software for Windows and STATISTICA 5, 
StatSoft Inc., for Windows and MS Excel 2002. 
RESULTS AND DISCUSSION
Both serum ceruloplasmin and urinary copper 
excretion represent the basic parameters of copper 
metabolism assessment.
Ceruloplasmin
Ceruloplasmin is a copper-bearing protein that 
binds approximately 90% of circulating copper in 
healthy individuals. Its normal concentration is 0,2-
0,4 g/L and values less than 0,2 g/L suggest the pres-
ence of WD. The estimation of the serum ceruloplas-
min is a useful diagnostic test. This level is, usually, 
abnormally low in WD. However, it should be kept in 
mind that 10-20% of the patients present with cerulo-
plasmin level at the low borderline or within normal 
limits (1,2,15-17). Ceruloplasmin is an acute-phase 
protein and its concentration increases in response to 
inflammation, infection and injury and that is why 
falsely-elevated as well as normal values can occur in 
some patients. On the other hand, diminished con-
centrations can be established under conditions of 
malnutrition and hypoproteinemia.
Our own data indicate that serum ceruloplas-
min values are lower in WD patients than in those 
with other CLD (Fig. 1).
In 55 WD patients (84,62% of the cases), the 
value of this parameter remains below the reference 
limits while in 10 ones (15,38% of the cases) it is with-
in the normal range that is close to the results report-
ed by other authors (8,11).
Comparison of ceruloplasmin levels between 
the patients with WD and with other CLD
Statistical hypothesis testing concerning the 
mean ceruloplasmin values and according to the log-
ic of t-test in independent samples has been carried 
out. These values are statistically significantly low-
er in the patients with WD than in those with other 
CLD, i. e. 0,149 g/L±0,067 g/L versus 0,224 g/L±0,062 
g/L. Our data are similar to the results reported else-
where and indicate the usefulness of this diagnostic 
parameter (7,8,11). However, the cases with a normal 
serum ceruloplasmin level in our continent of WD 
patients should not be ignored and the diagnosis of 
the disease could not be excluded. The results from t-
test analysis are presented on Fig. 2.
Urinary copper excretion
Although urinary copper excretion is elevat-
ed in most WD patients it does not result in any 
negative copper balance (10). The measurement of 
24-hour cupriuria is another reliable test. It is use-
ful for the diagnosis of the disease and monitoring 
of the treatment as well. This parameter reflects the 
amount of copper that remains not bound to blood 
ceruloplasmin. A great part of copper is bound to al-
bumins and amino acids. The copper that is bound 
to the amino acids is filtrated through the glomerules 
while albumin-bound copper is not filtrated except 
for the cases of significant proteinuria. Under these 
conditions, protein loss enhances cupriuria. Serum 
albumin is another factor that is probably involved in 
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the determination of the copper amount excreted by 
the urine. The low albumin level will enable a great-
er quantity of copper to find weaker ligands thus en-
abling the more intensive copper filtration through 
the glomerules (19). It is accepted that cupriuria over 
1,6 µmol/24 hours i.e. over 100 µg/24 hours is a reli-
able diagnostic test in a clinically manifested disease 
(1,2,11,13-15,17). Some authors report a high speci-
ficity of this diagnostic test (11).The values over 0,64 
µmol/24 hours are strongly indicative of WD and re-
quire further examinations (3,16).
Comparative analysis of mean basal urinary 
copper values in WD and other CLD
The descriptive analysis demonstrates that the 
mean spontaneous level of cupriuria in WD patients 
is 4,67 µmol/24 hours at a standard deviation of 
4,666 µmol/24 hours. These values are much higher 
than those in CLD patients. The considerable differ-
ence between the corresponding values can be seen 
on Table 1 and Table 2.
There is evidence that the mean values of spon-
taneous cupriuria between both groups of patients 
Fig. 1. Patient’s distribution according to ceruloplasmin levels (in g/L)
Fig. 2. Serum ceruloplasmin levels in patients with WD and with CLD
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are statistically different. The equal variance as-
sumed can reach up to 6,033 μmol/24 hours while the 
equal variances not assumed can reach up to 4,973 
μmol/24 hours at a confidence interval (CI) of 95% 
when these two groups are compared. However, this 
test can’t be performed in patients with renal failure. 
Its interpretation is hampered by the presence of sim-
ilar findings in other liver diseases such as autoim-
mune hepatitis, chronic cholestasis and acute liver 
failure. The considerable variations in WD patients 
are, probably, related to group heterogeneity includ-
ing different age, time lag between the onset of symp-
toms and the diagnosis of WD, clinical form and se-
verity of WD as well. The mean cupriuria value is by 
four times higher than the upper normal range and 
is considerably higher than that of the control group. 
That is why this parameter contributes to the correct 
diagnosis of WD.
Comparative analysis of mean provoked uri-
nary copper concentrations in WD and other CLD
D-penicillamine-induced cupriuria, i. e. D-pen-
icillamine challenge test, is an important and useful 
additional diagnostic test (5,7,9,12,13,18). The level of 
induced 24-hour cupriuria is by five times higher the 
upper normal range in WD patients. It amounts to 
17,40 3,13 μmol/24 hours while the corresponding 
values in the patients with other CLD are by approxi-
mately three times lower (5,46±2,99 µmol/24 hours). 
This difference is statistically significant and can be 
explained by a certain disorder of copper metabolism 
in WD (Table 3). This deals with the upper reference 
limits and the control group as well.
There is a five-fold increase over the normal 
range in 38 WD patients as well as a ten-fold one in 
10 of these patients. The elevation of copper excre-
tion in comparison with its initial level by more than 
five times in 24 WD patients is of importance, too. 
This fact enables us to consider this test useful, nec-
essary and applicable diagnostic parameter, especial-
ly in the cases of inexplicable hepatomegaly, vague 
liver disease, elements of hemolysis or unspecified 
neurological disease.  
Leipzig scoring system for diagnosis of WD
During the 8th International Conference on 
WD and Menkes disease in Leipzig in 2001, a scor-
ing system for the diagnosis of WD was suggested. Its 
purpose is to warrant objective criteria of high speci-
ficity and sensitivity for WD. A combination of clini-
cal and laboratory tests within a score range between 
zero and four has been elaborated. It includes the fol-
lowing parameters: Kayser-Fleischer ring, neurolog-
ical symptoms, serum ceruloplasmin, Coombs-neg-
ative hemolytic anemia, copper concentration in the 
hepatic tissue or staining for copper with rhodanine 
in the hepatocytes, spontaneous and/or provoked 
urinary copper excretion, and mutation analysis. 
This scoring system is incorporated into the clinical 
practice guidelines for WD approved by the Europe-
an Association for Study of the Liver (EASL) in 2012 
(3,4).
In 2010, we introduced this system in the Clinic 
of Gastroenterology and subsequently evaluated all 
the patients with WD according to it. Along the pa-
rameters of copper metabolism, the rest items of this 
integrated scoring system were analyzed.
We established neurological symptoms in 35 
patients. Out of them, 32 patients presented with a 
mixed hepatic and neurological form and the rest 
three did with solely neurological manifestations. 
Coombs-negative hemolytic anemia was proved in 
seven patients. Kayser-Fleischer ring was observed 
in 23 patients. DNA analysis was accomplished in 54 
patients. In 26 of them (48,15% of the cases), there 
were АТР7В gene mutations. Twenty-three patients 
(35,38% of the cases) underwent percutaneous as-
piration liver biopsy. A histochemical examination 
with rhodanine for copper detection was carried out 
in 19 patients. A positive result was obtained in 10 
patients (52,63% of the cases).
The distribution of the patients with WD and 
with other CLD according to the criteria of Leipzig 
scoring system is demonstrated on Fig. 3.
According to this system, 58 patients (89,23% 
of the cases) present with a score sum over four that 
proves the diagnosis of WD. Score of four occupies 
the greatest relative share of WD patients - 26,2%. 
The relative share of the patients with score of five 
and six is 12,3%. The relative share of 7,7% is equal 
for the patients with scores of 7, 8 and 11 as well. Sev-
en patients (10,77%) present with score of three. In 
them, the viral, autoimmune and toxic reasons for a 
CLD have been excluded. Clinical observation and 
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S.E. mean (µmol/24 
hours)
 WD 61 4,670 4,666 0,597
CLD 17 0,871 0,362 0,088
Table 1. Basal urinary copper concentrations in patients with WD and with CLD 
(descriptive statistics)
Dependent variables/Independent samples test
Assumptions Levene’s test 
for equality of 
variances
t-test for equality of means













6,237 62,516 0,000 11,942 0,604 2,559 4,973
Table 2. Basal urinary copper concentrations in patients with WD and with CLD 
(results from a statistical hypothesis)
Fig. 3. Patients’ distribution according to the Leipzig scoring system
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favourable therapeutic influence on the laborato-
ry parameters has confirmed the diagnosis in these 
patients. Only four patients with other CLD present 
with score of three while the rest 13 ones (76,47%) do 
with a score that is less or equal to two. The patients 
with a score of one occupy the greatest relative share 
in the control group. These results demonstrate that 
the parameters incorporated in the Leipzig scoring 
system are a reliable combination of criteria for the 
precise and definite diagnosis of WD. It is notewor-
thy that there does not exist a unique parameter for 
this diagnosis at all. On the other hand, it is not cor-
rect to accept that all the parameters should obliga-
torily be abnormal. In this respect, the complex eval-
uation, clinical observation and, in some cases, the 
therapeutic test with D-penicillamine could help the 
correct diagnosis.
CONCLUSION
The diagnosis of WD is based on the complex 
assessment of a combination of various clinical signs 
and laboratory parameters. Our results show that se-
rum ceruloplasmin can be used mainly in combina-
tion with the rest of the parameters. We have proved 
the usefulness and necessity of the test of basal and, 
particularly, of the provoked urinary copper excre-
tion for the correct diagnosis of WD. Our experience 
gained with the application of the Leipzig scoring 
system indicates that this is a reliable combination 
of clinical, laboratory, genetic and morphological pa-
rameters. It can be helpful for the precise diagnosis of 
WD, especially in the patients with a subclinical liver 
damage with a view to the timely treatment and pre-
vention of the complications of this potentially cur-
able hereditary disease.
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